2024-04-10 11:00Dr. Reddy's Laboratories SADr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatmentmore
2024-04-02 11:10Helmholtz MunichScientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targetsmore
2024-03-14 07:31STADA Arzneimittel AGPress release: STADA continues with double-digit sales and profit growth in 2023One documentmore
2024-03-13 16:21FDX Fluid Dynamix GmbH4FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiXmore
2024-02-28 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘more
2024-02-28 11:07Helmholtz MunichRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmore
2024-02-23 10:28Leipzig Tourismus und Marketing GmbH5Pioneering Heart Surgery and Medical Congresses in LeipzigOne documentmore
2024-02-22 13:23Helmholtz MunichTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical TrialMore information on the therapeutic vaccine TherVacBmore
2024-02-19 17:05Helmholtz MunichWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and ComplicationsMore information on the therapeutic vaccine TherVacBmore
2024-02-01 10:02Sysmex Europe SEStrengthening the Direct Sales and Service System for Business Expansion in ItalyMore information on the therapeutic vaccine TherVacBOne documentmore
2024-01-26 13:50Biomay AGBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapymore
2023-12-06 16:00LTS Lohmann Therapie-Systeme AGLTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patchesmore
2023-11-16 10:27Fruit Vegetables EuropeTen benefits of a daily intake of citrus fruits during winter seasonmore
2023-10-31 10:00ARTTIC Innovation GmbH2PIONEER+ becomes Big Data Platform for Prostate Cancer of the EAU's UroEvidenceHubMore information on the therapeutic vaccine TherVacBmore
2023-10-12 14:01ARTTIC Innovation GmbH3EU Provides 1 Mio. to Researchers to Advance Personalised OncologyMore information on the therapeutic vaccine TherVacBOne documentmore
2023-10-12 14:00ARTTIC Innovation GmbHcanSERV Releases Open Call for Transnational Service ProvisionMore information on the therapeutic vaccine TherVacBOne documentmore
2023-10-02 17:06Helmholtz MunichDeepMB: A Deep Learning Framework For High-Quality Optoacoustic Imaging in Real-Timemore
2023-08-30 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsOne documentmore
2023-08-15 07:01STADA Arzneimittel AG2Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and SpecialtyOne documentmore
2023-08-08 08:00ARTTIC Innovation GmbH4PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data SetsMore information on the therapeutic vaccine TherVacBmore
2023-07-05 17:15Helmholtz MunichPotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitorsmore
2023-06-30 10:09ARTTIC Innovation GmbH2CARAMBA: New Hope for Multiple Myeloma PatientsMore information on the therapeutic vaccine TherVacBmore
2023-06-28 17:13Helmholtz MunichNew Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Inductionmore